Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$78M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$51.4M |
| 3 |
Alibaba
BABA
|
+$48.4M |
| 4 |
PG&E
PCG
|
+$38.2M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$32.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$27.8M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$22.4M |
| 3 |
McKesson
MCK
|
+$18.1M |
| 4 |
DraftKings
DKNG
|
+$15.1M |
| 5 |
Mastercard
MA
|
+$15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.36% |
| 2 | Healthcare | 10.23% |
| 3 | Industrials | 9.8% |
| 4 | Financials | 9.25% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1876
Hewlett Packard
HPE
$70.8B
| – | – |
-28,413
| Closed | -$276K |
|
1877
HP
HPQ
$27.2B
| – | – |
-11,362
| Closed | -$197K |
|
1878
HealthEquity
HQY
$8.81B
| – | – |
-7,323
| Closed | -$370K |
|
1879
Hormel Foods
HRL
$13.1B
| – | – |
-5,168
| Closed | -$241K |
|
1880
H&R Block
HRB
$6.62B
| – | – |
-13,762
| Closed | -$194K |
|
1881
Harrow
HROW
$1.54B
| – | – |
-29,601
| Closed | -$113K |
|
1882
CALL
HubSpot
HUBS
$12B
| – | – |
-20,000
| Closed | -$2.66M |
|
1883
Hexcel
HXL
$7.1B
| – | – |
-8,086
| Closed | -$301K |
|
1884
iBio
IBIO
$71M
| – | – |
-79
| Closed | -$42K |
|
1885
IBM
IBM
$222B
| – | – |
-1,908
| Closed | -$202K |
|
1886
ICU Medical
ICUI
$4.57B
| – | – |
-15,763
| Closed | -$3.18M |
|
|
IGMS
1887
DELISTED
IGM Biosciences
IGMS
| – | – |
-29,834
| Closed | -$1.68M |
|
1888
Illumina
ILMN
$33.1B
| – | – |
-3,205
| Closed | -$852K |
|
1889
Incyte
INCY
$25.9B
| – | – |
-4,461
| Closed | -$327K |
|
1890
Intuit
INTU
$100B
| – | – |
-6,372
| Closed | -$1.47M |
|
1891
Ionis Pharmaceuticals
IONS
$9.93B
| – | – |
-5,934
| Closed | -$281K |
|
1892
iQIYI
IQ
$1.01B
| – | – |
-14,970
| Closed | -$266K |
|
1893
Iron Mountain
IRM
$36.3B
| – | – |
-28,023
| Closed | -$667K |
|
1894
Intuitive Surgical
ISRG
$134B
| – | – |
-4,977
| Closed | -$822K |
|
1895
Gartner
IT
$12.4B
| – | – |
-37,460
| Closed | -$3.73M |
|
1896
iShares US Aerospace & Defense ETF
ITA
$14.2B
| – | – |
-200
| Closed | -$14K |
|
1897
Itron
ITRI
$4.38B
| – | – |
-3,893
| Closed | -$217K |
|
1898
Invesco
IVZ
$14.1B
| – | – |
-24,906
| Closed | -$226K |
|
|
1899
CALL
iShares Russell 2000 ETF
IWM
$81.9B
| – | – |
-422,700
| Closed | -$48.4M |
|
1900
JB Hunt Transport Services
JBHT
$25.9B
| – | – |
-3,441
| Closed | -$317K |
|
Similar funds
Michael Gelband's Q2 2020 Portfolio in Review
As of Q2 2020, Michael Gelband held 2,172 positions worth $3.85B, up 111% from $1.82B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Michael Gelband deployed $1.66B of net new capital in Q2 2020, opening 1,142 new positions and adding to 418 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Amazon, an estimated $27.8M trimmed.
- Michael Gelband's largest Q2 2020 buy was State Street SPDR S&P 500 ETF Trust: 266,338 shares worth $82.1M.
- Michael Gelband added most to PG&E in Q2 2020, an estimated $38.2M increase.
- Michael Gelband's biggest Q2 2020 reduction was Amazon, cutting an estimated $27.8M.
- Michael Gelband fully exited McKesson in Q2 2020, selling an estimated $18.1M.
- Michael Gelband's ten largest holdings make up 17% of its $3.85B portfolio in Q2 2020.
- Michael Gelband opened 1,142 new positions and closed 448 in Q2 2020.
- Michael Gelband's portfolio value rose 111% quarter-over-quarter to $3.85B.
Based on ExodusPoint Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.